金属β-乳糖酶对taniborbactam耐药性的结构基础
Salvador I Drusin1, Christophe Le Terrier2,3, Laurent Poirel2,4
1Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Rosario, Argentina.
Antimicrobial agents and chemotherapy
|December 8, 2023
概括
新的双循环酸盐抑制剂,如taniborbactam,可以对抗抗卡巴耐药的细菌. 然而,金属β-乳糖酶中的单个突变可以通过破坏抑制剂结合来引起耐药性,这对新型抗菌疗法构成了挑战.
科学领域:
- 微生物学 微生物学
- 药用化学 医学化学
- 计算生物学 计算生物学
背景情况:
- 金属β-乳酸酶 (MBLs) 是一种主要的威胁,在耐卡巴胺的格拉姆阴性病原体.
- 双循环酸盐,包括taniborbactam,代表了对抗MBLs的有希望的策略.
- 新兴的耐药性,如NDM-9逃离taniborbactam,需要了解耐药性机制.
研究的目的:
- 调查金属β-乳酸酶中对双循环酸盐抑制剂的耐药性的分子基础.
- 确定单个氨基酸替代物赋予对taniborbactam的耐药性的机制.
- 为设计下一代不太容易产生抗性的MBL抑制剂提供见解.
主要方法:
- 对接分析对接分析
- 蛋白质 - 配体相互作用的计算分析.
- 分析MBL活性部位的静电相互作用.
主要成果:
- 对taniborbactam的耐药性可能是由于抑制剂的侧链和MBL活性位点循环之间的静电相互作用被破坏而产生的.
- 在非必需的MBL残留物中单个氨基酸的替代可以导致taniborbactam的非生产性结合模式.
- 这种抵抗机制不仅仅局限于NDM-9,而且可以影响其他MBL变体.
结论:
- 在MBL中单点突变可能会意外导致对高级抑制剂如taniborbactam的耐药性.
- 了解这些耐药性机制对于持续开发有效的抗微生物疗法至关重要.
- 需要进一步的研究来设计规避常见抗药途径的MBL抑制剂.
相关概念视频
Defense Against Bacterial Pathogens
1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K


